Arbutus Biopharma Corporation ABUS Enterprise value

Enterprise value at other companies

Arrowhead ResearchARWR

$8.7B+418%

Gilead SciencesGILD

$179.93B+17.5%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

AnaptysBio, Inc.ANAB

$1.35B+176%

Avalo TherapeuticsAVTX

$886.04M+7,437%

Assembly BiosciencesASMB

$411.56M+702%

FAQ

What is Arbutus Biopharma Corporation's enterprise value?

Arbutus Biopharma Corporation (ABUS) reported enterprise value of $856.58M in Q1 2026.

How has Arbutus Biopharma Corporation's enterprise value changed year-over-year?

Arbutus Biopharma Corporation's enterprise value increased by 35.5% year-over-year, from $632.38M to $856.58M.

What is the long-term trend for Arbutus Biopharma Corporation's enterprise value?

Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's enterprise value has grown at a 16.1% compound annual growth rate (CAGR), from $430.94M to $907.82M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.